KronosRx: How Cedars-Sinai is Using AI ‘Avatars’ to Replace Animal Testing”
Nicholas Tatonetti, PhD, Vice Chair of Computational Biomedicine at Cedars-Sinai (image credit)
What You Should Know
– Cedars-Sinai has secured a $5.05M ARPA-H contract to build KronosRx, an AI platform that predicts drug toxicity by pairing…
Continue Reading
